These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 24058201)

  • 21. How ANGPTL3 Inhibition Will Help Our Clinical Practice?
    Bini S; Tramontano D; Minicocci I; Di Costanzo A; Tambaro F; D'Erasmo L; Arca M
    Curr Atheroscler Rep; 2023 Jan; 25(1):19-29. PubMed ID: 36607583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolomic Signature of Angiopoietin-Like Protein 3 Deficiency in Fasting and Postprandial State.
    Tikkanen E; Minicocci I; Hällfors J; Di Costanzo A; D'Erasmo L; Poggiogalle E; Donini LM; Würtz P; Jauhiainen M; Olkkonen VM; Arca M
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):665-674. PubMed ID: 30816800
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic and Pharmacologic Inactivation of ANGPTL3 and Cardiovascular Disease.
    Dewey FE; Gusarova V; Dunbar RL; O'Dushlaine C; Schurmann C; Gottesman O; McCarthy S; Van Hout CV; Bruse S; Dansky HM; Leader JB; Murray MF; Ritchie MD; Kirchner HL; Habegger L; Lopez A; Penn J; Zhao A; Shao W; Stahl N; Murphy AJ; Hamon S; Bouzelmat A; Zhang R; Shumel B; Pordy R; Gipe D; Herman GA; Sheu WHH; Lee IT; Liang KW; Guo X; Rotter JI; Chen YI; Kraus WE; Shah SH; Damrauer S; Small A; Rader DJ; Wulff AB; Nordestgaard BG; Tybjærg-Hansen A; van den Hoek AM; Princen HMG; Ledbetter DH; Carey DJ; Overton JD; Reid JG; Sasiela WJ; Banerjee P; Shuldiner AR; Borecki IB; Teslovich TM; Yancopoulos GD; Mellis SJ; Gromada J; Baras A
    N Engl J Med; 2017 Jul; 377(3):211-221. PubMed ID: 28538136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ANGPTL3 serum concentration and rare genetic variants in Finnish population.
    Tikka A; Metso J; Jauhiainen M
    Scand J Clin Lab Invest; 2017 Dec; 77(8):601-609. PubMed ID: 28972399
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cardiovascular and Metabolic Effects of ANGPTL3 Antisense Oligonucleotides.
    Graham MJ; Lee RG; Brandt TA; Tai LJ; Fu W; Peralta R; Yu R; Hurh E; Paz E; McEvoy BW; Baker BF; Pham NC; Digenio A; Hughes SG; Geary RS; Witztum JL; Crooke RM; Tsimikas S
    N Engl J Med; 2017 Jul; 377(3):222-232. PubMed ID: 28538111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events.
    Miida T; Hirayama S
    Curr Opin Lipidol; 2010 Feb; 21(1):70-5. PubMed ID: 19851103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular analysis of APOB, SAR1B, ANGPTL3, and MTTP in patients with primary hypocholesterolemia in a clinical laboratory setting: Evidence supporting polygenicity in mutation-negative patients.
    Blanco-Vaca F; Martin-Campos JM; Beteta-Vicente Á; Canyelles M; Martínez S; Roig R; Farré N; Julve J; Tondo M
    Atherosclerosis; 2019 Apr; 283():52-60. PubMed ID: 30782561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.
    Wang Y; Gusarova V; Banfi S; Gromada J; Cohen JC; Hobbs HH
    J Lipid Res; 2015 Jul; 56(7):1296-307. PubMed ID: 25954050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Silencing of ANGPTL 3 (angiopoietin-like protein 3) in human hepatocytes results in decreased expression of gluconeogenic genes and reduced triacylglycerol-rich VLDL secretion upon insulin stimulation.
    Tikka A; Soronen J; Laurila PP; Metso J; Ehnholm C; Jauhiainen M
    Biosci Rep; 2014 Dec; 34(6):e00160. PubMed ID: 25495645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Four novel mutations in APOB causing heterozygous and homozygous familial hypobetalipoproteinemia.
    Whitfield AJ; Marais AD; Robertson K; Barrett PH; van Bockxmeer FM; Burnett JR
    Hum Mutat; 2003 Aug; 22(2):178. PubMed ID: 12872264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ANGPTL3 gene variants in subjects with familial combined hyperlipidemia.
    Bea AM; Franco-Marín E; Marco-Benedí V; Jarauta E; Gracia-Rubio I; Cenarro A; Civeira F; Lamiquiz-Moneo I
    Sci Rep; 2021 Mar; 11(1):7002. PubMed ID: 33772079
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
    Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
    Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ANGPTL3 decreases very low density lipoprotein triglyceride clearance by inhibition of lipoprotein lipase.
    Shimizugawa T; Ono M; Shimamura M; Yoshida K; Ando Y; Koishi R; Ueda K; Inaba T; Minekura H; Kohama T; Furukawa H
    J Biol Chem; 2002 Sep; 277(37):33742-8. PubMed ID: 12097324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiopoietin-like 3 in lipoprotein metabolism.
    Kersten S
    Nat Rev Endocrinol; 2017 Dec; 13(12):731-739. PubMed ID: 28984319
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The angiopoietin-like protein 3: a hepatokine with expanding role in metabolism.
    Arca M; Minicocci I; Maranghi M
    Curr Opin Lipidol; 2013 Aug; 24(4):313-20. PubMed ID: 23839332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and genetic analysis of a family diagnosed with familial hypobetalipoproteinemia in which the proband was diagnosed with diabetes mellitus.
    Wang X; Wang D; Shan Z
    Atherosclerosis; 2015 Apr; 239(2):552-6. PubMed ID: 25733326
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between familial hypobetalipoproteinemia and the risk of diabetes. Is this the other side of the cholesterol-diabetes connection? A systematic review of literature.
    Noto D; Arca M; Tarugi P; Cefalù AB; Barbagallo CM; Averna MR
    Acta Diabetol; 2017 Feb; 54(2):111-122. PubMed ID: 27804036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lipoprotein(a) in homozygous familial hypercholesterolemia.
    Kraft HG; Lingenhel A; Raal FJ; Hohenegger M; Utermann G
    Arterioscler Thromb Vasc Biol; 2000 Feb; 20(2):522-8. PubMed ID: 10669652
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A form of familial hypobetalipoproteinaemia not due to a mutation in the apolipoprotein B gene.
    Fazio S; Sidoli A; Vivenzio A; Maietta A; Giampaoli S; Menotti A; Antonini R; Urbinati G; Baralle FE; Ricci G
    J Intern Med; 1991 Jan; 229(1):41-7. PubMed ID: 1995762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Different relationship between ANGPTL3 and HDL components in female non-diabetic subjects and type-2 diabetic patients.
    Zhao D; Yang LY; Wang XH; Yuan SS; Yu CG; Wang ZW; Lang JN; Feng YM
    Cardiovasc Diabetol; 2016 Sep; 15(1):132. PubMed ID: 27620179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.